• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTRAVASCULAR CATHETER

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON INFUSION THERAPY SYSTEMS INC. BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER; INTRAVASCULAR CATHETER Back to Search Results
Catalog Number 382554
Device Problems Loss of or Failure to Bond (1068); Degraded (1153); Device Damaged Prior to Use (2284); Device Disinfection Or Sterilization Issue (2909)
Patient Problem No Patient Involvement (2645)
Event Date 05/22/2018
Event Type  malfunction  
Manufacturer Narrative
Initial reporter phone: (b)(6).A device evaluation is anticipated, but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event Description
It was reported that the packaging of the bd insyte¿ autoguard¿ bc shielded iv catheter appeared to be degraded.The adhesive seal is opening spontaneously.Therefore, the product is no longer sterile.Found before use.No reports of serious injury or medical intervention noted.
 
Manufacturer Narrative
H.6.Investigation summary: device/bath history review findings: as this complaint was an mdr, dhr review was performed on the lot number 5219921.The product was manufactured on afa line 9 from august 13, 2015 thru august 14, 2015 and packaged on packaging line 11 from august 21, 2015 thru august 21, 2015.Review of the dhr¿s revealed all required challenges samples and testing was performed per specification in accordance with the set-up and in process sampling plans.Per review it was noted that there were no reject activity findings throughout the build of this lot that would impact the quality of the product.Set-up and in-process inspections (included but not limited) blister thickness, bad seal/cut/holes, seal transfer width and package leak test.These were performed on various stages throughout the process and all the inspections passed per specifications.Visual analysis: observations and testing: received 15 unused iag/bc 16ga units in partially opened package from the lot number 5219921.Visual/microscopic examination: two of the packages were partially opened at both ends of the blister pack.Two of the packages were partially opened at the top of the blister pack.Two of the packages were partially opened at the bottom of the blister pack.The seals of the remaining nine packages were not compromised.The analysis of top web adhesive: the product characteristics require a minimum of 1/8¿ seal transfer.This characteristic was met.In addition, the paper top web of the returned unit was analyzed.The analysis revealed an adequate of top web adhesive.The key variables that affect seal strength are: seal transfer/width and top web glue.Both of these variables were looked at during the investigation.Investigation conclusion: relationship of device to the reported incident: indeterminate.Comment: although the packages were observed to be partially opened, there was no physical evidence to confirm or to support manufacturing process related issues for the defect.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD INSYTE¿ AUTOGUARD¿ BC SHIELDED IV CATHETER
Type of Device
INTRAVASCULAR CATHETER
Manufacturer (Section D)
BECTON DICKINSON INFUSION THERAPY SYSTEMS INC.
9450 south state street
sandy UT 84070
MDR Report Key7601863
MDR Text Key111662085
Report Number1710034-2018-00317
Device Sequence Number1
Product Code FOZ
UDI-Device Identifier00382903825547
UDI-Public00382903825547
Combination Product (y/n)N
PMA/PMN Number
K110443
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,other,user facility
Type of Report Initial,Followup
Report Date 06/26/2018
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Other
Device Expiration Date07/31/2018
Device Catalogue Number382554
Device Lot Number5219921
Initial Date Manufacturer Received 05/25/2018
Initial Date FDA Received06/14/2018
Supplement Dates Manufacturer Received05/25/2018
Supplement Dates FDA Received06/26/2018
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Other;
-
-